Get alerted on the PharmaSources E-Newsletter and Pharma Sources Insight E-Compilation!
Note: You can unsubscribe from the alerts at any time.
Advertising

Another Anti-PD-L(1) Monoclonal Antibody Filed the IND Application in China to Join the 40+ Applicants! Sales of Keytruda to Rank Second in the World in 2019

PharmaSources/1°CNovember 14, 2019

Tag: Opdivo , Keytruda , Tecentriq , Imfinzi , PD-(L)1

PharmaSources Customer Service